Catherine Skari
-
Mar- 2025 -26 MarchNews
THE HIDDEN RISK | Worsening Anaemia Linked to Pregnancy in Individuals with β-Thalassaemia Minor
β-thalassaemia minor is a genetic blood disorder that typically causes mild anaemia which typically does not require medical treatment. However,…
Read More » -
21 March
-
Feb- 2025 -25 FebruaryNews
NEW STUDY | Pegcetacoplan Shows Potential in Managing CAD and wAIHA
This investigational therapy, which targets complement component C3, has demonstrated the ability to increase haemoglobin levels, reduce haemolysis, and improve…
Read More » -
19 FebruaryNews
INTERNATIONAL THALASSAEMIA DAY 2025 | Announcing This Year’s Theme
Guided by the powerful slogans #WeAre1 and #PatientsFirst, we reaffirm our collective commitment to ensuring that individuals living with thalassaemia are not just…
Read More » -
4 FebruaryNews
PAROXYSMAL NOCTURNAL HEMOGLOBINURIA | Patients May See Improved Outcomes with Ravulizumab
The findings showed that patients treated with ravulizumab demonstrated better adherence and persistence compared to those on other complement inhibitors.…
Read More » -
4 February
-
Jan- 2025 -28 January
-
27 JanuaryNews
JUST RELEASED | 5th Edition of TIF’s Guidelines for the Management of Transfusion Dependent β-Thalassaemia
This edition stands as a seminal resource that provides critical guidance and recommendations to healthcare professionals across various specialties, researchers…
Read More » -
17 JanuaryNews
TIF AI KNOWLEDGE BOT | Your Go-To Source for Thalassaemia Information
In the world of healthcare, staying informed is key. That is why the TIF AI Knowledge Bot is here to…
Read More » -
16 JanuaryTIF News
EDUCATIONAL WEBINAR ON HEART COMPLICATIONS IN HAEMOGLOBINOPATHIES | 30 January 2025
📌 Webinar Title: Management of Thalassaemia: Heart Complications in Haemoglobinopathies 📌 Date & Time: Thursday, 30 January 2025, 13:00 New…
Read More »
